BLUEBERRY THERAPEUTICS

blueberry-therapeutics-logo

Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art p... reclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.

#SimilarOrganizations #People #Financial #Website #More

BLUEBERRY THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2011-01-01

Address:
Alderley Edge, Cheshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.blueberrytherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
+01625238776

Email Addresses:
[email protected]

Total Funding:
23.26 M USD

Technology used in webpage:
Euro Google Maps Google Maps API Google Maps For Work Fasthosts


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

aimvion-as-logo

AimVion A/S

AimVion A/S is a privately held research and development company focused on peptide based drugs for inflammatory and autoimmune diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

avexxin-logo

Avexxin

Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases

nordic-rebalance-logo

Nordic Rebalance

Nordic Rebalance primarily focussed on developing a dietary treatment for irritable bowel syndrome and inflammatory bowel diseases.

otsuka-novel-products-logo

Otsuka Novel Products

Otsuka Novel Products is devoted to finding better solutions for tackling infectious diseases.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

prothix-logo

Prothix

Prothix is a protein biologics for inflammatory and coagulation disorders.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.


Current Advisors List

tony-sedgwick_image

Tony Sedgwick Life Science Advisor @ Blueberry Therapeutics
Advisor
2012-11-01

not_available_image

Huaizheng Peng Board OF Director @ Blueberry Therapeutics
Board_member

Current Employees Featured

david-cook_image

David Cook
David Cook Chief Scientific Officer @ Blueberry Therapeutics
Chief Scientific Officer
2013-10-01

john-ridden_image

John Ridden
John Ridden Chief Executive Officer @ Blueberry Therapeutics
Chief Executive Officer
2011-11-01

mark-hollingworth_image

Mark Hollingworth
Mark Hollingworth Director of Finance @ Blueberry Therapeutics
Director of Finance
2015-12-01

not_available_image

Susan Yau
Susan Yau Manager of the Office @ Blueberry Therapeutics
Manager of the Office
2016-10-01

juergen-dobmeyer_image

Juergen Dobmeyer
Juergen Dobmeyer Acting Chief Medical Officer @ Blueberry Therapeutics
Acting Chief Medical Officer

simon-wallwork_image

Simon Wallwork
Simon Wallwork Legal Counsel @ Blueberry Therapeutics
Legal Counsel

Founder


michael-j-davies_image

Michael J. Davies

Investors List

npif-maven-equity-finance_image

NPIF Maven Equity Finance

NPIF Maven Equity Finance investment in Venture Round - Blueberry Therapeutics

medical-incubator-japan_image

Medical Incubator Japan

Medical Incubator Japan investment in Series B - Blueberry Therapeutics

connecticut-skin-institute_image

Connecticut Skin Institute

Connecticut Skin Institute investment in Series B - Blueberry Therapeutics

china-medical-venture-investment-hk-limited_image

China Medical Venture Investment (HK) Limited

China Medical Venture Investment (HK) Limited investment in Series B - Blueberry Therapeutics

gm-c-life-sciences-fund_image

GM&C Life Sciences Fund

GM&C Life Sciences Fund investment in Venture Round - Blueberry Therapeutics

catapult-venture-managers_image

Catapult Ventures

Catapult Ventures investment in Venture Round - Blueberry Therapeutics

incline-equity-partners_image

Incline Equity Partners

Incline Equity Partners investment in Seed Round - Blueberry Therapeutics

sbri-healthcare_image

SBRI Healthcare

SBRI Healthcare investment in Grant - Blueberry Therapeutics

Official Site Inspections

http://www.blueberrytherapeutics.com Semrush global rank: 1.7 M Semrush visits lastest month: 14.2 K

  • Host name: 77.68.64.47
  • IP address: 77.68.64.47
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Blueberry Therapeutics" on Search Engine